February 11, 2026 12:11 am (IST)
GlaxoSmithKline records 11% growth for Q2
New Delhi, Nov 5 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the second quarter ended September 30, 2014.
The company's net sales were reported at Rs 1075 crores, which recorded a growth of 11% over 2013 with PAT at Rs. 160 crores growing by 9% for the same period and PBT at Rs 245 crores growing by 10%.
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are delighted to have delivered consistent growth as the category leader. The consumer sentiments are showing early signs of recovery and our brands are well poised to help consumers do more, feel better and live longer. Our relentless focus on science, innovation and customer, remains our key differentiator and helps us to stay ahead in the category."
"We continue to improve consumer’s experience with new products like the re-launched Horlicks with proven health benefits, ‘instantization’ and new positioning, highlighting its daily nutritional relevance. We also remain focused on our access strategy to ensure that our products are within the easy reach of our large consumer base,” Ahmed said.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Department of Posts, NSE sign MoU to advance financial inclusion through mutual fund distribution
Tue, Feb 10 2026
White House clarifies India–US trade deal after Trump’s ‘zero tariff’ claim sparks buzz
Tue, Feb 10 2026
Deepinder Goyal exit shock fades as Zomato parent Eternal rallies 6% to multi-month high
Tue, Feb 10 2026
India steals the spotlight at BIOFACH 2026 as ‘Country Of The Year'
Tue, Feb 10 2026
Street can’t ignore this stock! Sansera Engineering rockets 12% after Q3 numbers drop
Tue, Feb 10 2026
India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal
Mon, Feb 09 2026
JK Tyre stock rallies on robust Q3 results, margins expand sharply
Mon, Feb 09 2026
